🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Chosa Oncology AB (FRA:W5L)
Germany flag Germany · Delayed Price · Currency is EUR
0.0392
+0.0062 (18.79%)
At close: Nov 18, 2026

Chosa Oncology AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
11.3610.119.048.620.89
Amortization of Goodwill & Intangibles
0.650.730.680.770.67
Other Operating Expenses
-4.6-4.61-4.12-0.07-
Operating Expenses
7.46.235.69.321.56
Operating Income
-7.4-6.23-5.6-9.32-1.56
Interest Expense
--0.01-0.02-0.51-
Interest & Investment Income
0.4400.010-
Currency Exchange Gain (Loss)
-0.38-0.380.140.27-
Other Non Operating Income (Expenses)
-0.01-0.010-0-
EBT Excluding Unusual Items
-7.35-6.63-5.48-9.56-1.56
Merger & Restructuring Charges
----14.19-
Pretax Income
-7.35-6.63-5.48-23.75-1.56
Income Tax Expense
-1.01-1.01-0.710.19-0.19
Net Income
-6.34-5.61-4.77-23.94-1.36
Net Income to Common
-6.34-5.61-4.77-23.94-1.36
Net Income Growth
-----
Shares Outstanding (Basic)
8874696219
Shares Outstanding (Diluted)
8874696219
Shares Change
23.85%8.01%11.15%225.67%-
EPS (Basic)
-0.07-0.08-0.07-0.39-0.07
EPS (Diluted)
-0.07-0.08-0.07-0.39-0.07
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
EBITDA
-6.65-5.5-4.92-8.55-0.89
D&A For EBITDA
0.750.730.680.770.67
EBIT
-7.4-6.23-5.6-9.32-1.56